During the past decade, Mayo Clinic Department of Ophthalmology conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 7 clinical trials were completed, i.e. on average, 140% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 6 clinical trials were completed. i.e. 600% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Mayo Clinic Department of Ophthalmology" #1 collaborator was "National Eye Institute (NEI)" with 9 trials as a collaborator, "National Institutes of Health (NIH)" with 4 trials as a collaborator, "Regeneron Pharmaceuticals" with 3 trials as a collaborator, "Pediatric Eye Disease Investigator Group" with 2 trials as a collaborator and "Centro Medico ABC" with 1 trials as a collaborator. Other collaborators include 26 different institutions and companies that were collaborators in the rest 36 trials.

According to Clinical.Site data, the most researched conditions in "Mayo Clinic Department of Ophthalmology" are "Diabetic Macular Edema" (2 trials), "Amblyopia" (1 trials), "Exotropia" (1 trials), "Full-thickness Macular Holes (MH)" (1 trials) and "Intermittent Exotropia" (1 trials). Many other conditions were trialed in "Mayo Clinic Department of Ophthalmology" in a lesser frequency.

Most popular intervention types in "Mayo Clinic Department of Ophthalmology" are "Device" (5 trials), "Drug" (5 trials), "Procedure" (3 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "0.3 mg intravitreal ranibizumab" (1 trials), "1.25 mg intravitreal bevacizumab" (1 trials), "2-mg Intravitreous Aflibercept Injection" (1 trials), "2.0 mg intravitreal aflibercept" (1 trials) and "AEB071" (1 trials). Other intervention names were less common.

The vast majority of trials in "Mayo Clinic Department of Ophthalmology" are 10 trials for "All" genders.

Currently, there are NaN active trials in "Mayo Clinic Department of Ophthalmology". 1 are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Mayo Clinic Department of Ophthalmology, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Mayo Clinic Department of Ophthalmology, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".